Your browser doesn't support javascript.
loading
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.
Cosgrove, Nicola; Eustace, Alex J; O'Donovan, Peter; Madden, Stephen F; Moran, Bruce; Crown, John; Moulton, Brian; Morris, Patrick G; Grogan, Liam; Breathnach, Oscar; Power, Colm; Allen, Michael; Walshe, Janice M; Hill, Arnold D; Blümel, Anna; O'Connor, Darren; Das, Sudipto; Milewska, Malgorzata; Fay, Joanna; Kay, Elaine; Toomey, Sinead; Hennessy, Bryan T; Furney, Simon J.
Afiliación
  • Cosgrove N; Genomic Oncology Research Group, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Eustace AJ; School of Biotechnology, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • O'Donovan P; Genomic Oncology Research Group, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Madden SF; Data Science Centre, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Moran B; Conway Institute, University College Dublin, Dublin, Ireland.
  • Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • Moulton B; Clinical Oncology Development Europe, Dublin, Ireland.
  • Morris PG; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • Grogan L; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • Breathnach O; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • Power C; Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Allen M; Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Walshe JM; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • Hill AD; Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Blümel A; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • O'Connor D; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Das S; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Milewska M; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, 9, Ireland.
  • Fay J; RCSI Biobank Service, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, 9, Ireland.
  • Kay E; Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, 9, Ireland.
  • Toomey S; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, 9, Ireland.
  • Hennessy BT; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland. bryanhennessy@rcsi.ie.
  • Furney SJ; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, 9, Ireland. bryanhennessy@rcsi.ie.
NPJ Breast Cancer ; 9(1): 72, 2023 Sep 27.
Article en En | MEDLINE | ID: mdl-37758711
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Año: 2023 Tipo del documento: Article País de afiliación: Irlanda
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Año: 2023 Tipo del documento: Article País de afiliación: Irlanda